UPDATE : Tuesday, August 11, 2020
상단여백
Migraine drug market heats up with Ubrelvy’s arrival by Kim Yun-mi 2019-12-27 11:57
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results by Jeong Sae-im 2019-12-27 07:06
Dupixent to get coverage from January by Kim Yun-mi 2019-12-24 15:40
‘Korea still slow to expand benefit for new drugs’ by Kim Yun-mi 2019-12-24 15:37
Shanghai Ocumension to market Huonland's HA eyedrop by Lee Han-soo 2019-12-23 15:43
라인
Alteogen's growth hormone deficiency treatment wins orphan drug status by Lee Han-soo 2019-12-23 14:46
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market by Lee Han-soo 2019-12-23 11:23
Successful drug development – getting it right from the start by Lee Han-soo 2019-12-20 16:30
Pfizer wins Champix patent suit against 20 local generics makers by Jeong Sae-im 2019-12-20 16:28
Chemas to research anticancer treatment in Germany by Lee Han-soo 2019-12-20 15:18
라인
Bridge Biotherapeutics seeks IND status for lung cancer treatment by Lee Han-soo 2019-12-20 14:41
Boehringer Ingelheim stops developing Pharmaxis’ NASH treatment candidate by Lee Han-soo 2019-12-19 17:42
AstraZeneca, Korean partners launch joint project to accelerate bio-health innovation by Lee Han-soo 2019-12-19 17:40
AstraZeneca, SK Holdings celebrates manufacturing partnership by Lee Han-soo 2019-12-19 16:39
Daewoong wins sales approval for Nabota in UAE, Indonesia by Lee Han-soo 2019-12-19 12:09
라인
Crystal Genomics acquires Hwail as subsidiary by Lee Han-soo 2019-12-18 17:48
4 new botulinum toxins to undergo trials in crowded market by Jeong Sae-im 2019-12-18 15:29
‘Roche's Xofluza to revolutionize influenza antivirals’ by Lee Han-soo 2019-12-17 16:30
Novartis reaffirms efficacy of Tasigna in treating chronic myelogenous leukemia by Lee Han-soo 2019-12-17 14:48
CDK4/6+fulvestrant combo may get benefit in 1st half of 2020 by Kim Yun-mi 2019-12-17 11:59
여백
여백
여백
Back to Top